Cardlytics, Inc.

NasdaqGM:CDLX Voorraadrapport

Marktkapitalisatie: US$206.8m

Cardlytics Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Cardlytics heeft een totaal eigen vermogen van $69.7M en een totale schuld van $213.2M, wat de schuld-eigenvermogensverhouding op 305.9% brengt. De totale activa en totale passiva bedragen respectievelijk $399.4M en $329.7M.

Belangrijke informatie

305.9%

Verhouding schuld/eigen vermogen

US$213.24m

Schuld

Rente dekkingsration/a
ContantUS$66.99m
AandelenUS$69.70m
Totaal verplichtingenUS$329.70m
Totaal activaUS$399.39m

Recente financiële gezondheidsupdates

Recent updates

After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar

Nov 05
After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar

Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?

Oct 15
Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?

Cardlytics: Execution Risks Are Elevated, But Reasons For Optimism Remain (Maintain Hold Rating)

Sep 17

Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk

Aug 09
Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk

Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain

Jul 02

Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

May 31
Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

The Power Of Cardlytics' Data Partnerships Including Bank of America

Apr 17

Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors

Apr 10
Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors

Cardlytics: Good Prospects But Macro Uncertain

Feb 16

Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk

Jan 18
Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk

Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?

Jan 04
Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?

We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt

Oct 05
We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt

Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?

Jun 18
Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?

Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Apr 17
Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Mar 03
Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Jan 10
Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

Oct 12
Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

Cardlytics: 6 Bear Cases To Consider

Oct 10

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $183.3M ) CDLX } overtreffen de korte termijn passiva ( $155.9M ).

Langlopende schulden: De kortetermijnactiva CDLX ( $183.3M ) overtreffen de langetermijnschulden ( $173.8M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 209.8% ) CDLX wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van CDLX is de afgelopen 5 jaar gestegen van 0% naar 305.9%.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: CDLX heeft op basis van de huidige vrije kasstroom voldoende kasstroom voor meer dan een jaar.

Voorspelling contante baan: CDLX heeft voldoende kasruimte voor meer dan 3 jaar als de vrije kasstroom blijft dalen met een historisch percentage van 13.6 % per jaar.


Ontdek gezonde bedrijven